In the world of biotechnology entrepreneurship, especially in Brazil, the role of women is growing but still faces challenges. According to data from Sebrae, only 25% of startups in Brazil are founded by women, even though women represent about 60% of PhDs in science and technology fields. In this context, a recent episode of the podcast “Duas Pizzas” on the Vida Moderna channel brought to light the inspiring stories of three women changing this scenario. One of the episode’s protagonists is Dr. Patrícia Rozenchan, CSO of Celluris.
Celluris’ impact on immunotherapy
Celluris stands out in the biotechnology market for its innovative solutions in the development of CAR-T therapies, an advanced immunotherapy treatment that uses the patient’s own cells to fight cancer. Under the scientific leadership of Patrícia Rozenchan, the company is continuously seeking partnerships and investors to enhance its technologies and bring innovative treatments to more patients.
Celluris focuses on transforming oncology treatment by developing personalized and safe cell therapy solutions. CAR-T therapy is seen as one of the most promising breakthroughs in cancer treatment, especially for patients with hematologic diseases that do not respond well to conventional treatments.
About Patrícia Rozenchan: female leadership in biotechnology
Patrícia Rozenchan has a solid academic and scientific background. A graduate of the prestigious “Cancer Biology and Therapeutics” program at Harvard Medical School, she has over 20 years of experience in oncology, with a special focus on the study of the tumor microenvironment. Her PhD in Oncology and postdoctoral work in Molecular Biology from the Faculty of Medicine at the University of São Paulo bolster her expertise, making her a reference in the field.
As CSO of Celluris, Patrícia is responsible for the scientific strategy and establishing collaborations with health sector players, as well as directly engaging in investor negotiations to ensure the advancement of research and development of new treatments.
A female perspective on scientific entrepreneurship
The podcast episode “Duas Pizzas” focused on a relevant theme: the underrepresentation of women in startup entrepreneurship. Patrícia, along with two other scientists, Carolini Kaid and Luana Raposo de Melo, shared her experience as a biotechnology entrepreneur, discussing the challenges and achievements she has faced throughout her career.
The three scientists, who have remarkable trajectories in both academia and entrepreneurship, highlighted the importance of increasing female representation in this sector, not only to promote equal opportunities but also to bring new perspectives and innovative solutions to the market.
The role of women in startup entrepreneurship
Despite the growing female participation in academia, with a significant increase in the number of women with doctorates, entrepreneurship remains a male-dominated field. Women like Patrícia Rozenchan are changing this narrative by leading projects with a global impact, such as Celluris, which develops innovative solutions for cancer treatment.
Innovation and partnerships: pursuing the future of immunotherapy
One of Patrícia’s main responsibilities as CSO of Celluris is to ensure that the company remains at the forefront of innovation in immunotherapy. This involves seeking strategic partnerships with health institutions, universities, and other key players in the biotechnology field. Additionally, developing new treatments requires significant investment in research and clinical trials, making investor negotiations a crucial part of Patrícia’s work.
The CAR-T immunotherapy that Celluris develops is a revolutionary approach to cancer treatment, offering an alternative to traditional treatments like chemotherapy and showing promising results, especially for patients with aggressive or resistant types of cancer. The company is committed to expanding access to this technology in Brazil and internationally.
Future perspectives for celluris and science in Brazil
Brazil is emerging as an important hub of scientific innovation, especially in biotechnology. Startups like Celluris, led by scientists like Patrícia Rozenchan, are helping drive this growth. Women’s participation in this scenario is essential to ensure that the solutions developed reflect the diversity of thought and approaches needed to tackle global health challenges.
The story of Patrícia Rozenchan, shared on the podcast “Duas Pizzas,” serves as inspiration for future generations of women scientists and entrepreneurs. Her journey shows that despite the challenges, it is possible to achieve success in a competitive field like biotechnology, contributing significantly to science and society.
A transformative force in biotechnology
Celluris is at the forefront of biotechnology in Brazil, developing innovative immunotherapy solutions for cancer treatment. Patrícia’s participation in the “Duas Pizzas” podcast highlights not only scientific advances but also the challenges and achievements of women in entrepreneurship.
Biotechnology is an ever-evolving field, and the role of women as leaders and innovators is essential to ensure a more inclusive and equitable future for all. Patrícia Rozenchan’s work at Celluris is a clear example of how science can be a transformative force, bringing innovative solutions to complex problems like cancer.
To watch the full episode, click here. To read more content about Celluris and CAR-T immunotherapy, visit our news channel.
